PMA P230030S018

Device: FARAPULSE™ Pulsed Field Ablation System
Applicant: Farapulse, Inc.
PMA number: P230030
Supplement: S018
Product code: QZI
Decision date: 2026-08-06
Classification: Cardiovascular
Generic name: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation
Approval order statement: approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P230030/S012.

Current openFDA PMA Record#

Device: FARAPULSE™ Pulsed Field Ablation System
Applicant: Farapulse, Inc.
PMA number: P230030
Supplement: S018
Product code: QZI
Generic name: Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible Electroporation
Decision date: 2026-08-06
Decision code: APPR
Date received: 2026-02-11
Supplement type: Normal 180 Day Track No User Fee
Supplement reason: Postapproval Study Protocol
Approval order statement: approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P230030/S012.